VIPoma risk factors: Difference between revisions
Jump to navigation
Jump to search
Madhu Sigdel (talk | contribs) No edit summary |
Aditya Ganti (talk | contribs) |
||
| Line 3: | Line 3: | ||
{{CMG}}{{AE}}{{MSI}}{{PSD}} | {{CMG}}{{AE}}{{MSI}}{{PSD}} | ||
==Overview== | ==Overview== | ||
The most common risk factor in the development of VIPoma is positive family history of [[multiple endocrine neoplasia type 1]]. | The most common risk factor in the development of VIPoma is positive family history of [[multiple endocrine neoplasia type 1]]. | ||
==Risk Factors== | ==Risk Factors== | ||
The most common risk factor in the development of VIPoma is positive family history of [[multiple endocrine neoplasia type 1]]. | * The most common risk factor in the development of VIPoma is positive family history of [[multiple endocrine neoplasia type 1]]. | ||
* 90% of the cases of VIPoma are sporadic whereas MEN-1 account for only 10% cases. | |||
==References== | ==References== | ||
{{Reflist|1}} | {{Reflist|1}} | ||
Revision as of 19:22, 19 January 2018
|
VIPoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
VIPoma risk factors On the Web |
|
American Roentgen Ray Society Images of VIPoma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Madhu Sigdel M.B.B.S.[2]Parminder Dhingra, M.D. [3]
Overview
The most common risk factor in the development of VIPoma is positive family history of multiple endocrine neoplasia type 1.
Risk Factors
- The most common risk factor in the development of VIPoma is positive family history of multiple endocrine neoplasia type 1.
- 90% of the cases of VIPoma are sporadic whereas MEN-1 account for only 10% cases.